Source: FDA news release
July 16, 2016 (San Diego's East County) - The U.S. Food and Drug Administration yesterday approved the first intraocular lens (IOL) that provides cataract patients with an extended depth-of-focus, which helps improve their sharpness of vision (visual acuity) at near, intermediate and far distances.
Recent comments